Citations

Clear

3942 citation(s) found for "To, Van".

miR-219a-5p Regulates Rorβ During Osteoblast Differentiation and in Age-related Bone Loss
Aquino-Martínez, Rubén , Weivoda, Megan , Negley, Brittany A, Onken, Jennifer L, Thicke, Brianne S, Fulcer, McKenzie M, Fraser, Daniel G., Wijnen, André J. van , Rowsey, Jennifer L. , Farr, Joshua N. , Weivoda, Megan M, Monroe, David G. , van Wijnen, Andre J , Fulcer, McKenzie M., Khosla, Sundeep

Mayo Clinic

Journal of Bone and Mineral Research | October 15, 2018 | Volume: 34 | Issue: 1 | Pages: 135-144

10.1002/jbmr.3586 | PMID 30321475 Get It

ABSTRACT Developing novel approaches to treat skeletal disorders requires an understanding of how critical molecular factors regulate osteoblast differentiation and bone remodeling. We have reported that (1) retinoic acid receptor-related orphan receptor beta (Rorβ) is upregulated in bone samples isolated from aged mice and humans in vivo; (2) Rorβ expression is inhibited during osteoblastic differentiation in vitro; and (3) genetic deletion of Rorβ in mice results in preservation of bone mass during aging. These data establish that Rorβ inhibits osteogenesis and that strict control of Rorβ expression is essential for bone homeostasis. Because microRNAs (miRNAs) are known to play important roles in the regulation of gene expression in bone, we explored whether a predicted subset of nine miRNAs regulates Rorβ expression during both osteoblast differentiation and aging. Mouse osteoblastic cells were differentiated in vitro and assayed for Rorβ and miRNA expression. As Rorβ levels declined with differentiation, the expression of many of these miRNAs, including miR-219a-5p, was increased. We further demonstrated that miR-219a-5p was decreased in bone samples from old (24-month) mice, as compared with young (6-month) mice, concomitant with increased Rorβ expression. Importantly, we also found that miR-219a-5p expression was decreased in aged human bone biopsies compared with young controls, demonstrating that this phenomenon also occurs in aging bone in humans. Inhibition of miR-219a-5p in mouse calvarial osteoblasts led to increased Rorβ expression and decreased alkaline phosphatase expression and activity, whereas a miR-219a-5p mimic decreased Rorβ expression and increased osteogenic activity. Finally, we demonstrated that miR-219a-5p physically interacts with Rorβ mRNA in osteoblasts, defining Rorβ as a true molecular target of miR-219a-5p. Overall, our findings demonstrate that miR-219a-5p is involved in the regulation of Rorβ in both mouse and human bone. © 2018 American Society for Bone and Mineral Research.
Effect of Ascertainment Bias on Estimates of Patient Mortality in Inherited Cardiac Diseases
Nannenberg, Eline A., Rijsingen, Ingrid A.W. van, Zwaag, Paul A. van der , Berg, Maarten P. van den , Tintelen, J. Peter van , Tanck, Michael W.T. , Ackerman, Michael J. , Wilde, Arthur A.M. , Christiaans, Imke , van Tintelen, J Peter , Tanck, Michael , van den Berg, Maarten P

Mayo Clinic

Circulation: Genomic and Precision Medicine | October 12, 2018 | Volume: 11 | Issue: 10 | Pages: No page available

10.1161/circgen.117.001797 | PMID 30354299 Get It

Background: Accurate estimates of survival are indispensable for cardiologists, clinical geneticists, and genetic counselors dealing with families with an inherited cardiac disease. However, a bias towards a more severe disease with a worse outcome in the first publications may not accurately represent the actual survival forecast. We, therefore, evaluated the effect of ascertainment bias on survival in 3 different inherited cardiac diseases (idiopathic ventricular fibrillation, SCN5A overlap syndrome, and arrhythmogenic cardiomyopathy) caused by a founder mutation. Methods: We collected mortality data from mutation-positive subjects with either DPP6 -associated idiopathic ventricular fibrillation, SCN5A overlap syndrome, and PLN -R14del-mediated arrhythmogenic cardiomyopathy >2 to 10 years of ongoing clinical/cascade genetic screening. Results: The median age of survival in DPP6 mutation-positive subjects increased from 44.6 years in the original cohort from 2008 (n=60; 95% CI, 36.8–52.4 years) to 68.2 years in the extended cohort from 2012 (n=235; 95% CI, 64.6–71.7 years; P <0.001). In the SCN5A overlap syndrome, survival increased from 56.1 years in 1999 (n=86; 95% CI, 48.0–64.2 years) to 69.7 years in 2009 (n=197; 95% CI, 61.3–78.2 years; P =0.049). In PLN -R14del positive patients, the median age of survival increased from 63.5 years in 2010 (n=89; 95% CI, 59.1–68.0 years) to 65.2 years in 2012 (n=370; 95% CI, 62.0–68.3 years; P =0.046). Conclusions: The median age of survival in 3 different inherited cardiac diseases with an established pathogenic substrate significantly increased once genetic testing and cascade screening extended, after the first publication that elucidated the discovery of the disease-susceptibility gene/mutation. This underscores the direct and negative influence of ascertainment bias on survival forecasts and the importance of ongoing clinical/genetic follow-up to establish the most accurate disease prognosis for genetically mediated heart diseases.
Ibrutinib significantly inhibited Bruton’s tyrosine kinase (BTK) phosphorylation,in-vitro proliferation and enhanced overall survival in a preclinical Burkitt lymphoma (BL) model
Chu, Yaya, Shah, Tishi, Yin, Changhong , Barth, Matthew J. , Miles, Rodney R., Ayello, Janet, Morris, Erin , Harrison, Lauren , Ven, Carmella van de , Galardy, Paul J. , Goldman, Stanton, Lim, Megan S. , Hermiston, Michelle L. , McAllister‐Lucas, Linda M. , Giulino‐Roth, Lisa , Perkins, Sherrie L., Cairo, Mitchell S. , Galardy, Paul J , Lee, Sanghoon , Lim, Megan S

Mayo Clinic

OncoImmunology | October 11, 2018 | Volume: 8 | Issue: 1 | Pages: No page available

10.1080/2162402x.2018.1512455 | PMID 30546948 Get It

Intramyocardial Hematoma After Radiofrequency Catheter Ablation
Chen, Joy C.Y., Wackel, Philip L. , Dorn, Charlotte S. Van , Sinak, Lawrence J., Van Dorn, Charlotte S, Chen, Joy C.Y., Corban, Michel , Dearani, Joseph A.

Mayo Clinic

Circulation Journal | October 5, 2018 | Volume: 83 | Issue: 5 | Pages: 1083

10.1253/circj.cj-18-0550 | PMID 30298833 Get It

Robust radiotherapy planning
Unkelbach, Jan , Alber, M., Bangert, Mark, Bokrantz, Rasmus, Chan, Timothy C. Y. , Deasy, Joseph O. , Fredriksson, Albin , Gorissen, Bram L. , Herk, Marcel van , Liu, Wei , Mahmoudzadeh, Houra , Nohadani, Omid , Siebers, Jeffrey V. , Xu, Huijun , Witte, Marnix , Xu, Huijun , Liu, Wei

Mayo Clinic

Physics in Medicine & Biology | October 5, 2018 | Volume: 63 | Issue: 22 | Pages: 22TR02

10.1088/1361-6560/aae659 | PMID 30418942 Get It

Abstract Motion and uncertainty in radiotherapy is traditionally handled via margins. The clinical target volume (CTV) is expanded to a larger planning target volume (PTV), which is irradiated to the prescribed dose. However, the PTV concept has several limitations, especially in proton therapy. Therefore, robust and probabilistic optimization methods have been developed that directly incorporate motion and uncertainty into treatment plan optimization for intensity modulated radiotherapy (IMRT) and intensity modulated proton therapy (IMPT). Thereby, the explicit definition of a PTV becomes obsolete and treatment plan optimization is directly based on the CTV. Initial work focused on random and systematic setup errors in IMRT. Later, inter-fraction prostate motion and intra-fraction lung motion became a research focus. Over the past ten years, IMPT has emerged as a new application for robust planning methods. In proton therapy, range or setup errors may lead to dose degradation and misalignment of dose contributions from different beams – a problem that cannot generally be addressed by margins. Therefore, IMPT has led to the first implementations of robust planning methods in commercial planning systems, making these methods available for clinical use. This paper first summarizes the limitations of the PTV concept. Subsequently, robust optimization methods are introduced and their applications in IMRT and IMPT planning are reviewed.
Comparing the International Classification of Functioning, Disability, and Health Core Sets for Hearing Loss and Otorhinolaryngology/Audiology Intake Documentation at Mayo Clinic
Alfakir, Razan , Leeuwen, Lisette M. van , Pronk, Marieke , Kramer, Sophia E. , Zapala, David A., van Leeuwen, Lisette M, Alfakir, Razan

Mayo Clinic

Ear & Hearing | October 5, 2018 | Volume: 40 | Issue: 4 | Pages: 858-869

10.1097/aud.0000000000000662 | PMID 30289788 Get It

Objectives: The International Classification of Functioning, Disability, and Health (ICF) Core Sets for Hearing Loss (CSHL) consists of short lists of categories from the entire ICF classification that are thought to be the most relevant for describing the functioning of persons with hearing loss. A comprehensive intake that covers all factors included in the ICF CSHL holds the promise of developing a tailored treatment plan that fully complements the patient’s needs. The Comprehensive CSHL contains 117 categories and serves as a guide for multiprofessional, comprehensive assessment. The Brief CSHL includes 27 of the 117 categories and represents the minimal spectrum of functioning of persons with HL for single-discipline encounters or clinical trials. The authors first sought to benchmark the extent to which Audiologist (AUD) and Otorhinolaryngologist (ORL) discipline-specific intake documentation, as well as Mayo Clinic’s multidisciplinary intake documentation, captures ICF CSHL categories. Design: A retrospective study design including 168 patient records from the Department of Otorhinolaryngology/Audiology of Mayo Clinic in Jacksonville, Florida. Anonymized intake documentation forms and reports were selected from patient records filed between January 2016 and May 2017. Data were extracted from the intake documentation forms and reports and linked to ICF categories using pre-established linking rules. “Overlap,” defined as the percentage of ICF CSHL categories represented in the intake documentation, was calculated across document types. In addition, extra non–ICF CSHL categories (ICF categories that are not part of the CSHL) and extra constructs (constructs that are not part of the ICF classification) found in the patient records were described. Results: The total overlap of multidisciplinary intake documentation with ICF CSHL categories was 100% for the Brief CSHL and 50% for the Comprehensive CSHL. Brief CSHL overlap for discipline-specific documentation fell short at 70% for both AUD and ORL. Important extra non–ICF CSHL categories were identified and included “sleep function” and “motor-related functions and activities,” which mostly were reported in relation to tinnitus and vestibular disorders. Conclusion: The multidisciplinary intake documentation of Mayo Clinic showed 100% overlap with the Brief CSHL, while important areas of nonoverlap were identified in AUD- and ORL-specific reports. The ICF CSHL provides a framework for describing each hearing-impaired individual’s unique capabilities and needs in ways currently not documented by audiological and otological evaluations, potentially setting the stage for more effective individualized patient care. Efforts to further validate the ICF CSHL may require the involvement of multidisciplinary institutions with commonly shared electronic health records to adequately capture the breath of the ICF CSHL.
Effect of Early Surgery vs Physical Therapy on Knee Function Among Patients With Nonobstructive Meniscal Tears
Noorduyn, Julia C. A. , Butter, Ise K., Gast, Arthur de , Saris, Daniël B.F. , Poolman, Rudolf W. , Graaf, Victor A. van de , Willigenburg, Nienke Willemien , Mol, Ben W , Twisk, Jos W. R.

Mayo Clinic

JAMA | October 3, 2018 | Volume: 320 | Issue: 13 | Pages: 1328

10.1001/jama.2018.13308 | PMID 30285177 Get It

The Rapidly Assessed Predictor of Intraoperative Damage (RAPID) Score: An In-Clinic Predictive Model for High-Grade Acetabular Chondrolabral Disruption
Hartigan, David E. , Wu, Isabella T. , Desai, Vishal S. , Wijnen, André J. van , Saris, Daniël B.F. , Levy, Bruce A. , Krych, Aaron J. , Wyles, Cody C. , van Wijnen, Andre J , Krych, Aaron J , Hevesi, Mario , Desai, Vishal

Mayo Clinic

Orthopaedic Journal of Sports Medicine | October 3, 2018 | Volume: 6 | Issue: 10 | Pages: No page available

10.1177/2325967118799068 | PMID 30302348 Get It

Background: The preoperative assessment of cartilage lesions is critical to surgical planning and decision making. The accurate radiographic determination of acetabular cartilage damage has remained elusive for modern imaging modalities, including magnetic resonance imaging (MRI) and magnetic resonance arthrography (MRA). While risk factors have been individually described, no multivariable system exists for predicting high-grade cartilage damage. Purpose: To determine the preoperative predictors of grade 3 to 4 acetabular labrum articular disruption (ALAD) lesions. Study Design: Case-control study; Level of evidence, 3. Cohort study (diagnosis); Level of evidence, 1. Methods: Retrievable radiographs were reviewed from primary hip arthroscopic procedures performed at 2 high-volume institutions between December 2007 and April 2017. The predictive value of demographic and radiographic factors for the intraoperative documentation of ALAD grade 3 to 4 damage was analyzed and entered into a multivariable model, and a statistically guided scoring system for the damage risk was created using the Akaike information criterion. The scoring system was then prospectively validated on 167 patients who underwent primary hip arthroscopy between April 2017 and February 2018. Results: A total of 652 primary hip arthroscopic procedures in 614 patients (390 female, 224 male; mean age, 33.2 ± 12.5 years; mean body mass index, 26.9 ± 5.5 kg/m 2 ) from 2007 to 2017 were analyzed. Male sex (odds ratio [OR], 3.11; P < .01), age ≥35 years (OR, 1.96; P < .01), cam morphology (alpha angle >55°) (OR, 2.96; P < .01), and Tönnis grade 1 to 2 (grade 1: OR, 4.14; P < .01, and grade 2: OR, 9.29; P < .01) were univariate risk factors for intraoperatively documented high-grade damage. A multivariable scoring system, the Rapidly Assessed Predictor of Intraoperative Damage (RAPID) score (0-5 points), was generated based on sex, Tönnis grade, and cam morphology. Patients with increasing RAPID scores had an increasing risk of damage, with a 10.5% risk for those with 0 points and an 88.0% risk for those with 5 points ( P < .01). The area under the curve was 0.75 for the study group and 0.76 for the validation group ( P = .94). Conclusion: While preoperative MRI has diagnostic value for hip arthroscopic surgery, the RAPID score provides added benefit as a readily employable, in-clinic system for predicting high-grade cartilage damage. The discriminatory value of the RAPID score compares favorably with previous MRI and MRA studies. This information will help the clinician and patient plan for high-grade damage and identify potential targets for cartilage treatment.
Mate pair sequencing improves detection of genomic abnormalities in acute myeloid leukemia
Aypar, Umut , Smoley, Stephanie A., Pitel, Beth A. , Pearce, Kathryn E., Zenka, Roman M. , Vasmatzis, George , Johnson, Sarah H. , Smadbeck, James B. , Peterson, Jess F. , Geiersbach, Katherine B. , Dyke, Daniel L. Van , Thorland, Erik C., Jenkins, Robert B. , Greipp, Patricia T. , Kearney, Hutton M. , Hoppman, Nicole L., Van Dyke, Daniel L, Peterson, Jess F , Pitel, Beth A , Greipp, Patricia T , Ketterling, Rhett P. , Baughn, Linda B. , Aypar, Umut , Geiersbach, Katherine

Mayo Clinic

European Journal of Haematology | October 1, 2018 | Volume: 102 | Issue: 1 | Pages: 87-96

10.1111/ejh.13179 | PMID 30270457 Get It

AbstractObjectiveAcute myeloid leukemia (AML) can be subtyped based on recurrent cytogenetic and molecular genetic abnormalities with diagnostic and prognostic significance. Although cytogenetic characterization classically involves conventional chromosome and/or fluorescence in situ hybridization (FISH) assays, limitations of these techniques include poor resolution and the inability to precisely identify breakpoints.MethodWe evaluated whether an NGS‐based methodology that detects structural abnormalities and copy number changes using mate pair sequencing (MPseq) can enhance the diagnostic yield for patients with AML.ResultsUsing 68 known abnormal and 20 karyotypically normal AML samples, each recurrent primary AML‐specific abnormality previously identified in the abnormal samples was confirmed using MPseq. Importantly, in eight cases with abnormalities that could not be resolved by conventional cytogenetic studies, MPseq was utilized to molecularly define eight recurrent AML‐fusion events. In addition, MPseq uncovered two cryptic abnormalities that were missed by conventional cytogenetic studies. Thus, MPseq improved the diagnostic yield in the detection of AML‐specific structural rearrangements in 10/88 (11%) of cases analyzed.ConclusionUtilization of MPseq represents a precise, molecular‐based technique that can be used as an alternative to conventional cytogenetic studies for newly diagnosed AML patients with the potential to revolutionize the diagnosis of hematologic malignancies.
Obesity and hemoglobin content impact peak oxygen uptake in human heart failure
Iterson, Erik H. Van , Kim, Chul‐Ho , Uithoven, Katelyn E., Olson, Thomas P. , Uithoven, Katelyn, Van Iterson, Erik H

Mayo Clinic

European Journal of Preventive Cardiology | September 24, 2018 | Volume: 25 | Issue: 18 | Pages: 1937-1946

10.1177/2047487318802695 | PMID 30247068 Get It

Background Exercise intolerance, obesity, and low hemoglobin (hemoglobin<13 and <12 g/dl, men/women, respectively) are common features of heart failure. Despite serving as potent contributors to metabolic dysfunction, the impact of obesity and low hemoglobin on exercise intolerance is unknown. This study tested the hypotheses, compared with non-obese (NO) heart failure with normal hemoglobin, (a) counterparts with low hemoglobin and obesity or non-obesity will demonstrate reduced peak exercise oxygen uptake; (b) obese with normal hemoglobin will demonstrate decreased peak exercise oxygen uptake; (c) compared across stratifications, obese with low hemoglobin will demonstrate the sharpest decrement in peak exercise oxygen uptake. Methods Adults with heart failure ( n = 315; left ventricular ejection fraction≤40%; 77% men) (Group 1: normal hemoglobin and non-obese, n = 137; Group 2: low hemoglobin and non-obese, n = 51; Group 3: normal hemoglobin+obesity, n = 89; Group 4, n = 38: low hemoglobin+obesity; body mass index = 26 ± 3, 26 ± 2, 34 ± 4, 34 ± 4 kg/m 2 , respectively) completed treadmill cardiopulmonary exercise testing as part of routine clinical management. Peak exercise oxygen uptake was measured via standard metabolic system. Results There were no group-wise differences for heart failure class, gender, left ventricular ejection fraction, and resting cardiopulmonary function. Group 1 demonstrated increased peak exercise oxygen uptake versus Groups 2–4 (20 ± 6 versus 17 ± 6, 17 ± 5, 13 ± 4 ml/kg/min, respectively; all p < 0.001); whereas Group 4 peak exercise oxygen uptake was reduced versus all groups ( p < 0.001). Additionally, both body mass index (R 2 = 0.10) and hemoglobin (R 2 = 0.12) were significant predictors of peak exercise oxygen uptake in Group 1; which were relationships not mirrored for Groups 2–4. Conclusion These data suggest obesity together with low hemoglobin are potent contributors to impaired peak exercise oxygen uptake and, hence, oxidative metabolic capacity. In diverse populations of heart failure where obesity and/or low hemoglobin are present, it is important to consider these features together when interpreting peak exercise oxygen uptake and underlying exercise limitations.